Virus News and Research

Latest Virus News and Research

Scientists develop new cancer immunotherapy treatment for children with high-risk solid tumors

Recently, research using adoptive T-cell immunotherapy in blood cancers have shown success, most notably in the case of a seven-year-old girl whose leukemia went into remission using altered T-cells and a disabled HIV virus.

4 Apr 2013

Finding solutions to protect U.S. troops against invisible killers

A Saint Louis University researcher has received a contract worth up to $980,000 to see if two cancer medications have the potential of protecting U.S. troops from biological agents that could be unleashed during an attack.

4 Apr 2013

GPEI announces 'endgame' plan to eradicate polio by 2018

"A new global plan aims to end most cases of polio by late next year, and essentially eradicate the paralyzing disease by 2018 -- if authorities can raise the $5.5 billion needed to do the work, health officials said Tuesday," the Associated Press reports (Neergaard, 4/2).

4 Apr 2013

China reports 4 more cases of H7N9 bird flu virus; Officials investigating route of transmission

"On Tuesday, China reported four more cases of infection with the H7N9 influenza virus, a type of bird flu, in the eastern Jiangsu province," Time reports.

4 Apr 2013

Viewpoints: Obama's brain initiative is 'modest but welcome start;' Disability insurance facing 'immediate crisis'

President Obama officially announced his new brain research initiative on Tuesday, with a pledge to put $100 million in his 2014 budget to support work at three federal agencies.

4 Apr 2013

FDA approves Mylan's ANDA for generic version of Zovirax Ointment

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Acyclovir Ointment USP, 5%.

4 Apr 2013

Injuries caused by sharp instruments are major occupational hazard for surgeons

Injuries caused by needles and other sharp instruments are a major occupational hazard for surgeons—with high costs related to the risk of contracting serious infectious diseases, according to a special article in the April issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).

3 Apr 2013

UAB School of Nursing offers health care services in rural communities

"If individuals, families, and communities don't have access, then they don't have the opportunity for a better life," asserts University of Alabama at Birmingham School of Nursing Dean Doreen C. Harper, PhD, RN, FAAN.

3 Apr 2013

U.S. agencies supporting fight against HIV/AIDS in Malawi

"U.S. agencies that work to fight HIV this week began a five-year effort with Malawi's government to improve health care for Malawians infected with the virus," VOA News reports.

3 Apr 2013

Salk neuroscientist applauds launch of BRAIN Initiative

Salk neuroscientist Terrence J. Sejnowski joined President Barack Obama in Washington, D.C., on April 2, 2013, at the launch of the Brain Research through Advancing Innovative Neurotechnologies Initiative-a major Administration neuroscience effort that advances and builds upon collaborative scientific work by leading brain researchers such as Salk's own Sejnowski.

3 Apr 2013

LSUHSC researchers study common STI

Research led by David H. Martin, MD, Professor and Chief of Infectious Diseases at LSU Health Sciences Center New Orleans, has found that a common sexually transmitted infection-causing parasite "cultivates" bacteria beneficial to it, changing thinking about which comes first-infection or bacteria.

3 Apr 2013

Antibodies neutralize mosquito-transmitted chikungunya virus, researchers reveal

Researchers have learned the precise structure of the mosquito-transmitted chikungunya virus pathogen while it is bound to antibodies, showing how the infection is likely neutralized.

3 Apr 2013

Biogen acquires TYSABRI stake from Elan

Biogen Idec today announced it has completed its purchase of Elan Corporation's interest in TYSABRI (natalizumab) and has gained full strategic, commercial and decision-making rights to TYSABRI.

3 Apr 2013

Study: Pradaxa drug may increase risk and severity of viral infections

A study led by researchers at the University of North Carolina indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral infections, including flu and myocarditis, a viral infection of the heart and a significant cause of sudden death in children and young adults.

2 Apr 2013

Inovio Pharmaceuticals reports release of phase II clinical trial results of ChronVac-C

Inovio Pharmaceuticals, Inc. today announced the release of preliminary clinical trial results by its collaborator ChronTech AS of their open label phase II clinical study of ChronVac-C, ChronTech's vaccine to treat hepatitis C virus infection.

2 Apr 2013

Scientists get inside look at how AIDS virus grooms its assault team

A new study by Los Alamos National Laboratory and University of Pennsylvania scientists defines previously unknown properties of transmitted HIV-1, the virus that causes AIDS.

2 Apr 2013

Researchers use common virus to modify adult stem cells

Using the same strategy that a common virus employs to evade the human immune system, researchers at Wake Forest Baptist Medical Center's Institute for Regenerative Medicine have modified adult stem cells to increase their survival - with the goal of giving the cells time to exert their natural healing abilities.

2 Apr 2013

BioCryst Pharmaceuticals receives preliminary comment letter from FDA on peramivir

BioCryst Pharmaceuticals, Inc. announced that it received a preliminary comment letter from the U.S. Food & Drug Administration that outlines a pathway by which BioCryst could file a New Drug Application seeking regulatory approval of intravenous (i.v.) peramivir.

1 Apr 2013

New study shows varicella vaccine neutralizes chicken pox

Chicken pox, the childhood affliction of earlier generations, has been largely neutralized by the varicella vaccine, according to a new study by the Kaiser Permanente Vaccine Study Center, which appears in the current online issue of Pediatrics.

1 Apr 2013

New technique for vaccine design could prove useful against HIV, other viral strains

A team led by scientists from The Scripps Research Institute (TSRI) and the International AIDS Vaccine Initiative (IAVI) has unveiled a new technique for vaccine design that could be particularly useful against HIV and other fast-changing viruses.

30 Mar 2013

Virus News and Research

Latest Virus News and Research

Scientists develop new cancer immunotherapy treatment for children with high-risk solid tumors

Finding solutions to protect U.S. troops against invisible killers

GPEI announces 'endgame' plan to eradicate polio by 2018

China reports 4 more cases of H7N9 bird flu virus; Officials investigating route of transmission

Viewpoints: Obama's brain initiative is 'modest but welcome start;' Disability insurance facing 'immediate crisis'

FDA approves Mylan's ANDA for generic version of Zovirax Ointment

Injuries caused by sharp instruments are major occupational hazard for surgeons

UAB School of Nursing offers health care services in rural communities

U.S. agencies supporting fight against HIV/AIDS in Malawi

Salk neuroscientist applauds launch of BRAIN Initiative

LSUHSC researchers study common STI

Antibodies neutralize mosquito-transmitted chikungunya virus, researchers reveal

Biogen acquires TYSABRI stake from Elan

Study: Pradaxa drug may increase risk and severity of viral infections

Inovio Pharmaceuticals reports release of phase II clinical trial results of ChronVac-C

Scientists get inside look at how AIDS virus grooms its assault team

Researchers use common virus to modify adult stem cells

BioCryst Pharmaceuticals receives preliminary comment letter from FDA on peramivir

New study shows varicella vaccine neutralizes chicken pox

New technique for vaccine design could prove useful against HIV, other viral strains

A new way of characterising biomolecules eBook

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Newsletters you may be interested in